New Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them? - The New York Times (Thanks to Willa and Jackie for this one)
 |
| When John Ebers, a commercial beekeeper in Comstock Park, Mich., was diagnosed with Stage 3 colorectal cancer, he was not given the option of genetic testing, which could have revealed if there were drugs that could attack his cancer. Credit...Emily Elconin for The New York Times |
